Skip to content Skip to footer
Who we are

Profound expertise in biotechnology, particularly genome editing, virology, cell biology, drug development and commercialization.

PROVIREX is a spin-off of the Leibniz Institute of Virology (LIV) and is based in Hamburg, Germany.

OUR TEAM

Management

Oliver Ahnfeld

Co-Founder CEO/CFO

PD Dr. Jan Chemnitz MBA

Co-Founder CEO/CSO

Dr. Niklas Beschorner

Co-Founder Head of RnD

Dr. Maike Voges

Co-Founder Head of QM

OUR TEAM

Consultants

Dr. Ilona Hauber

Co-Founder

PROVIREX
Genome Editing Therapies GmbH

Luruper Hauptstraße 1
22547 Hamburg

Germany

mail@provirex.com

Copyright © PROVIREX Genome Editing Therapies GmbH 2023